Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price was up 0.9% during mid-day trading on Tuesday . The stock traded as high as $4.66 and last traded at $4.60. Approximately 209,392 shares changed hands during trading, a decline of 16% from the average daily volume of 248,358 shares. The stock had previously closed at $4.56.
Ono Pharmaceutical Stock Performance
The stock has a 50 day moving average price of $4.30 and a 200 day moving average price of $3.92.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty?pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co?developing and commercializing nivolumab (Opdivo), an anti–PD?1 immune checkpoint inhibitor developed in partnership with Bristol?Myers Squibb.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
